eMedicine Specialties > Gastroenterology > Intestine

Intestinal Pseudo-obstruction, Surgical Treatment

Author: Burt Cagir, MD, FACS, Assistant Professor of Surgery, State University of New York, Upstate Medical Center; Consulting Staff, Director of Surgical Research, Robert Packer Hospital; Associate Program Director, Department of Surgery, Guthrie Clinic
Coauthor(s): Lena M Napolitano, MD, FACS, FCCP, FCCM, Professor of Surgery, University of Michigan School of Medicine; Chief, Surgical Critical Care, Program Director, Surgical Critical Care Fellowship, Associate Chair, Department of Surgery, University of Michigan Health System; James Dunne, MD, Clinical Instructor, Department of Surgery, Trauma/Critical Care, University of Maryland Medical Center
Contributor Information and Disclosures

Updated: May 1, 2008

Introduction

The term intestinal pseudo-obstruction is used to indicate a syndrome characterized by a clinical picture suggestive of mechanical obstruction in the absence of any demonstrable evidence of such an obstruction in the intestine.1 Based on clinical presentation, pseudo-obstruction syndromes can be divided into acute and chronic forms. Acute colonic pseudo-obstruction is a clinical condition that appears with symptoms, signs, and radiological findings similar to those of acute large bowel obstruction, without any apparent mechanical cause.2

In 1948, Sir Heneage Ogilvie described 2 cases of massive colonic dilatation without any mechanical obstruction. Despite a normal barium enema finding, both patients underwent an exploratory laparotomy for persistent symptoms. Both were found to have malignant infiltration in the region of the celiac axis and semilunar ganglion without evidence of a mechanical obstruction. Ogilvie concluded that the symptoms were caused by an imbalance in the autonomic nerve supply to the colon, with an emphasis on what he called "sympathetic deprivation."3

Problem

Intestinal pseudo-obstruction, acute colonic pseudo-obstruction, and Ogilvie syndrome are defined as the symptoms, signs, and radiological appearance of acute large intestinal obstruction unrelated to any mechanical cause.

Frequency

Studies involving more than 13,000 orthopedic and burn patients documented the prevalence of acute colonic pseudo-obstruction to be 0.29%.4,5 The incidence in patients undergoing major orthopedic surgery may be higher, with reported rates of 0.65-1.3%.6 The true incidence of this disorder remains largely unknown because of the possibility of spontaneous resolution.

Acute colonic pseudo-obstruction generally develops in hospitalized patients and is associated with a variety of medical and surgical conditions. Studies have documented that up to 95% of the cases of acute colonic pseudo-obstruction are associated with medical or surgical conditions, with the rest being classified as idiopathic.7,2,8 The most commonly associated conditions include trauma, pregnancy, cesarean delivery, severe infections, and cardiothoracic, pelvic, or orthopedic surgery.9,10,11,12

The mean age of patients with acute colonic pseudo-obstruction appears to be increasing. In 1986, Vanek et al reviewed more than 400 cases of colonic pseudo-obstruction occurring between 1970-1985 and documented the mean age of patients to be 56.5 years for females and 59.9 years for males.13 In the late 1980s, other reports also documented the mean age to be in the sixth decade.14,15 Several reports have since documented an increase in the mean age of patients with acute colonic pseudo-obstruction. Most reports now indicate the mean age to be in the seventh and eighth decades of life.16,5,17,12  

Unlike age, the male-to-female ratio (1.5-4:1) has apparently remained constant over the years.14,13,18,19

Mortality/Morbidity: Because of the associated medical and surgical conditions, the morbidity and mortality rates associated with colonic pseudo-obstruction remain high. In 1993, Datta and colleagues documented an annual death rate in the United Kingdom of 200 patients per year; most of these deaths occurred in elderly bedridden patients.20 The mortality rate in medically treated patients has been documented to be 14%; in surgically treated patients, 30%.13 The most serious complication of colonic pseudo-obstruction is perforation of the cecum. The reported incidence of cecal perforation is 3-40%, and the associated mortality rate is 40-50%.

Pathophysiology

Since Ogilvie's original description of the syndrome, the exact pathophysiology remains unknown. Current theories continue to suggest the idea of an imbalance in the autonomic nervous system. In contrast to Ogilvie's original proposal, these theories focus on the increased sympathetic tone, the decreased parasympathetic tone, or a combination of both as the cause for colonic pseudo-obstruction.21,22 One theory, supported by Lee and colleagues' 1988 study, relies on the fact that increased sympathetic tone to the colon results in the inhibition of colonic motility.23 By using epidural anesthesia to block the splanchnic sympathetics, these authors successfully treated several patients whose acute colonic pseudo-obstructions did not respond to conservative management.24 A more recent report on the use of spinal anesthesia for the treatment of Ogilvie syndrome also supports this hypothesis.25

Another theory regarding the etiology of intestinal pseudo-obstruction focuses on the parasympathetic tone. The vagus nerve supplies the parasympathetic innervations for the upper gastrointestinal tract down to the splenic flexure of the colon. From this point, the parasympathetic innervation is via the lumbar nerves from the spinal segments S2 to S4. Given the parasympathetic distribution, one theory hypothesizes that if the sacral innervation becomes disrupted, the distal colon may be left atonic, thus resulting in a functional obstruction.26,21,27,24 This theory is in agreement with studies showing a transition between a dilated and collapsed bowel that is often at or near the splenic flexure.28,13

Other investigators believe that the disorder is a result of a combination of increased sympathetic and decreased parasympathetic tone. In 1992, Hutchinson et al reported successfully treating 8 of 11 patients with colonic pseudo-obstruction by using the sympathetic adrenergic blocker guanethidine, followed by the cholinesterase-inhibitor neostigmine.29

Presentation

Acute colonic pseudo-obstruction occurs most commonly in debilitated, hospitalized patients and is associated with a wide variety of medical and surgical conditions.7,9,10,11,8,12 Surgical patients begin developing symptoms, which are often insidious in onset, an average of 3-5 days after their operative procedure.13,5,2 Whether this disorder is associated with either medical or surgical conditions, the presenting signs and symptoms are similar.

Vanek et al documented the presence of abdominal distention in virtually all patients with colonic pseudo-obstruction.13 A more recent report documented that the most relevant clinical finding in Ogilvie syndrome is abdominal distention, which arises suddenly, has a progressive course, and may worsen.30 Most patients had abdominal pain, nausea, vomiting, and constipation. Diarrhea and the passage of small amounts of flatus were also present in a number of patients. The most dramatic physical finding was massive abdominal distention. Fever was present in 37% of patients. Abnormal bowel sounds (ie, high-pitched, hyperactive, hypoactive) were present in 88% of patients; 12% had no detectable bowel sounds.

Abdominal tenderness was noted in patients with perforated or ischemic bowel and in patients with viable bowel. No significant differences were noted in the symptoms of patients with ischemic or perforated bowel compared with patients with viable bowel except for a higher incidence of fever (78% vs 31%). Digital examination revealed an empty rectum.13,27

Indications

See Treatment.

Relevant Anatomy

The large intestine consists of the cecum, ascending colon, hepatic flexure, transverse colon, splenic flexure, descending colon, sigmoid colon, and rectum. The cecum is located in the iliac fossa.  The cecum and ascending colon are saccular, are larger in diameter, and have thinner wall properties when they are compared to the descending colon, sigmoid colon, and rectum. Therefore, one should be extremely careful in avoiding iatrogenic perforation of the cecum and ascending colon while manipulating in the operating room for laparoscopic or open cecostomy and segmental colectomy.

Contraindications

Contraindications to the surgical correction of intestinal pseudo-obstruction are based on the patient's comorbidities and his or her ability to tolerate surgery.

More on Intestinal Pseudo-obstruction, Surgical Treatment

Overview: Intestinal Pseudo-obstruction, Surgical Treatment
Workup: Intestinal Pseudo-obstruction, Surgical Treatment
Treatment: Intestinal Pseudo-obstruction, Surgical Treatment
Follow-up: Intestinal Pseudo-obstruction, Surgical Treatment
Multimedia: Intestinal Pseudo-obstruction, Surgical Treatment
References

References

  1. Coulie B, Camilleri M. Intestinal pseudo-obstruction. Annu Rev Med. 1999;50:37-55. [Medline].

  2. Alwan MH, van Rij AM. Acute colonic pseudo-obstruction. Aust N Z J Surg. Feb 1998;68(2):129-32. [Medline].

  3. Olgilvie H. Large-intestine colic due to sympathetic deprivation. BMJ. 1948;2:671-673.

  4. Kadesky K, Purdue GF, Hunt JL. Acute pseudo-obstruction in critically ill patients with burns. J Burn Care Rehabil. Mar-Apr 1995;16(2 Pt 1):132-5. [Medline].

  5. Clarke HD, Berry DJ, Larson DR. Acute pseudo-obstruction of the colon as a postoperative complication of hip arthroplasty. J Bone Joint Surg Am. Nov 1997;79(11):1642-7. [Medline].

  6. Norwood MG, Lykostratis H, Garcea G, Berry DP. Acute colonic pseudo-obstruction following major orthopaedic surgery. Colorectal Dis. Sep 2005;7(5):496-9. [Medline].

  7. Nanni G, Garbini A, Luchetti P, Nanni G, Ronconi P, Castagneto M. Ogilvie's syndrome (acute colonic pseudo-obstruction): review of the literature (October 1948 to March 1980) and report of four additional cases. Dis Colon Rectum. Mar 1982;25(2):157-66. [Medline].

  8. Laine L. Management of acute colonic pseudo-obstruction. N Engl J Med. Jul 15 1999;341(3):192-3. [Medline].

  9. Ravo B, Pollane M, Ger R. Pseudo-obstruction of the colon following cesarean section. A review. Dis Colon Rectum. Jul 1983;26(7):440-4. [Medline].

  10. Geelhoed GW. Colonic pseudo-obstruction in surgical patients. Am J Surg. Feb 1985;149(2):258-65. [Medline].

  11. Anuras S, Baker CR Jr. The colon in the pseudoobstructive syndrome. Clin Gastroenterol. Oct 1986;15(4):745-62. [Medline].

  12. Tenofsky PL, Beamer L, Smith RS. Ogilvie syndrome as a postoperative complication. Arch Surg. Jun 2000;135(6):682-6; discussion 686-7. [Medline].

  13. Vanek VW, Al-Salti M. Acute pseudo-obstruction of the colon (Ogilvie's syndrome). An analysis of 400 cases. Dis Colon Rectum. Mar 1986;29(3):203-10. [Medline].

  14. Fausel CS, Goff JS. Nonoperative management of acute idiopathic colonic pseudo-obstruction (Ogilvie's syndrome). West J Med. Jul 1985;143(1):50-4. [Medline].

  15. Sloyer AF, Panella VS, Demas BE, Shike M, Lightdale CJ, Winawer SJ, et al. Ogilvie's syndrome. Successful management without colonoscopy. Dig Dis Sci. Nov 1988;33(11):1391-6. [Medline].

  16. Geller A, Petersen BT, Gostout CJ. Endoscopic decompression for acute colonic pseudo-obstruction. Gastrointest Endosc. Aug 1996;44(2):144-50. [Medline].

  17. Paran H, Silverberg D, Mayo A, Shwartz I, Neufeld D, Freund U. Treatment of acute colonic pseudo-obstruction with neostigmine. J Am Coll Surg. Mar 2000;190(3):315-8. [Medline].

  18. Marinella MA. Acute colonic pseudo-obstruction complicated by cecal perforation in a patient with Parkinson's disease. South Med J. Oct 1997;90(10):1023-6. [Medline].

  19. Trevisani GT, Hyman NH, Church JM. Neostigmine: safe and effective treatment for acute colonic pseudo- obstruction. Dis Colon Rectum. May 2000;43(5):599-603. [Medline].

  20. Datta SN, Stephenson BM, Havard TJ, Salaman JR. Acute colonic pseudo-obstruction. Lancet. Mar 13 1993;341(8846):690. [Medline].

  21. Bachulis BL, Smith PE. Pseudoobstruction of the colon. Am J Surg. Jul 1978;136(1):66-72. [Medline].

  22. Manten HD. Pseudo-obstruction. In: Haubrich WS, Schaffner F, Berk JE eds. Bockus Gastroenterology. Vol 2. Philadelphia: WB Saunders Co; 1995:1249-1267.

  23. Lee JT, Taylor BM, Singleton BC. Epidural anesthesia for acute pseudo-obstruction of the colon (Ogilvie's syndrome). Dis Colon Rectum. Sep 1988;31(9):686-91. [Medline].

  24. Christensen J. Intestinal motor physiology. In: Sleisenger MH, Fordtran JS, eds. Gastrointestinal Disease: Pathophysiology, Diagnosis, Management. 6th ed. Philadelphia: WB Saunders Co; 1998:1437-1450.

  25. Mashour GA, Peterfreund RA. Spinal anesthesia and Ogilvie's syndrome. J Clin Anesth. Mar 2005;17(2):122-3. [Medline].

  26. Spira IA, Wolff WI. Gangrene and spontaneous perforation of the cecum as a complication of pseudo-obstruction of the colon: report of three cases and speculation as to etiology. Dis Colon Rectum. Sep 1976;19(6):557-62. [Medline].

  27. Dorudi S, Berry AR, Kettlewell MG. Acute colonic pseudo-obstruction. Br J Surg. Feb 1992;79(2):99-103. [Medline].

  28. Ellis H. Pseudo-obstruction of the colon. In: Ellis H, ed. Intestinal Obstruction. NY: Appleton-Century-Crofts; 1982:81-86.

  29. Hutchinson R, Griffiths C. Acute colonic pseudo-obstruction: a pharmacological approach. Ann R Coll Surg Engl. Sep 1992;74(5):364-7. [Medline].

  30. Grassi R, Cappabianca S, Porto A, Sacco M, Montemarano E, Quarantelli M, et al. Ogilvie's syndrome (acute colonic pseudo-obstruction): review of the literature and report of 6 additional cases. Radiol Med (Torino). Apr 2005;109(4):370-5. [Medline].

  31. Nivatvongs S, Vermeulen FD, Fang DT. Colonoscopic decompression of acute pseudo-obstruction of the colon. Ann Surg. Nov 1982;196(5):598-600. [Medline].

  32. Anuras S, Shirazi SS. Colonic pseudoobstruction. Am J Gastroenterol. Jul 1984;79(7):525-32. [Medline].

  33. Gilchrist AM, Mills JO, Russell CG. Acute large-bowel pseudo-obstruction. Clin Radiol. Jul 1985;36(4):401-4. [Medline].

  34. Low VH. Colonic pseudo-obstruction: value of prone lateral view of the rectum. Abdom Imaging. Nov-Dec 1995;20(6):531-3. [Medline].

  35. Stewart J, Finan PJ, Courtney DF, Brennan TG. Does a water soluble contrast enema assist in the management of acute large bowel obstruction: a prospective study of 117 cases. Br J Surg. Oct 1984;71(10):799-801. [Medline].

  36. Koruth NM, Koruth A, Matheson NA. The place of contrast enema in the management of large bowel obstruction. J R Coll Surg Edinb. Aug 1985;30(4):258-60. [Medline].

  37. Finan PJ, Stewart J, Brennan TG. Pseudo-obstruction. Br Med J (Clin Res Ed). Jun 14 1986;292(6535):1594-5. [Medline].

  38. Phillips S, Pemberton JH. Acute megacolon. In: Sleisenger MH, Fordtran JS, eds. Gastrointestinal Disease: Pathophysiology, Diagnosis, Management. Philadelphia: WB Saunders Co; 1998:1817-1818.

  39. Breccia M, Girmenia C, Mecarocci S, Cartoni C, Carmosino I, Tafuri A, et al. Ogilvie's syndrome in acute myeloid leukemia: pharmacological approach with neostigmine. Ann Hematol. Oct 2001;80(10):614-6. [Medline].

  40. Bjorgen J, Bonella F. Gravity treatment of pseudo-obstruction of the colon. Minn Med. Nov 1987;70(11):623. [Medline].

  41. Wegener M, Börsch G. Acute colonic pseudo-obstruction (Ogilvie's syndrome). Presentation of 14 of our own cases and analysis of 1027 cases reported in the literature. Surg Endosc. 1987;1(3):169-74. [Medline].

  42. Attar A, Lémann M, Ferguson A, Halphen M, Boutron MC, Flourié B, et al. Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation. Gut. Feb 1999;44(2):226-30. [Medline].

  43. Rex DK. Colonoscopy and acute colonic pseudo-obstruction. Gastrointest Endosc Clin N Am. Jul 1997;7(3):499-508. [Medline].

  44. Turegano-Fuentes F, Munoz-Jimenez F, Del Valle-Hernandez E, Perez-Diaz D, Calvo-Serrano M, De Tomas J, et al. Early resolution of Ogilvie's syndrome with intravenous neostigmine: a simple, effective treatment. Dis Colon Rectum. Nov 1997;40(11):1353-7. [Medline].

  45. Cakir E, Baykal S, Usul H, Kuzeyli K, Cinel A. Ogilvie's syndrome after cervical discectomy. Clin Neurol Neurosurg. Dec 2001;103(4):232-3. [Medline].

  46. Bonacini M, Smith OJ, Pritchard T. Erythromycin as therapy for acute colonic pseudo-obstruction (Ogilvie's syndrome). J Clin Gastroenterol. Aug 1991;13(4):475-6. [Medline].

  47. Mazloum BW, Barnes JB, Lee M. Cisapride as a successful treatment for acute intestinal pseudo-obstruction. South Med J. Aug 1996;89(8):828-30. [Medline].

  48. Catchpole BN. Ileus: use of sympathetic blocking agents in its treatment. Surgery. Nov 1969;66(5):811-20. [Medline].

  49. Stephenson BM, Morgan AR, Salaman JR, Wheeler MH. Ogilvie's syndrome: a new approach to an old problem. Dis Colon Rectum. Apr 1995;38(4):424-7. [Medline].

  50. Ponec RJ, Saunders MD, Kimmey MB. Neostigmine for the treatment of acute colonic pseudo-obstruction. N Engl J Med. Jul 15 1999;341(3):137-41. [Medline].

  51. Saunders MD, Kimmey MB. Systematic review: acute colonic pseudo-obstruction. Aliment Pharmacol Ther. Nov 15 2005;22(10):917-25. [Medline].

  52. De Giorgio R, Barbara G, Stanghellini V, Tonini M, Vasina V, Cola B, et al. Review article: the pharmacological treatment of acute colonic pseudo-obstruction. Aliment Pharmacol Ther. Nov 2001;15(11):1717-27. [Medline].

  53. Abeyta BJ, Albrecht RM, Schermer CR. Retrospective study of neostigmine for the treatment of acute colonic pseudo-obstruction. Am Surg. Mar 2001;67(3):265-8; discussion 268-9. [Medline].

  54. van der Spoel JI, Oudemans-van Straaten HM, Stoutenbeek CP, Bosman RJ, Zandstra DF. Neostigmine resolves critical illness-related colonic ileus in intensive care patients with multiple organ failure--a prospective, double-blind, placebo-controlled trial. Intensive Care Med. May 2001;27(5):822-7. [Medline].

  55. St John PH, Radcliffe AG. Contraindication for the use of neostigmine in colonic pseudo-obstruction. Br J Surg. Oct 1997;84(10):1481-2. [Medline].

  56. Kukora JS, Dent TL. Colonoscopic decompression of massive nonobstructive cecal dilation. Arch Surg. Apr 1977;112(4):512-7. [Medline].

  57. Bode WE, Beart RW Jr, Spencer RJ, Culp CE, Wolff BG, Taylor BM. Colonoscopic decompression for acute pseudoobstruction of the colon (Ogilvie's syndrome). Report of 22 cases and review of the literature. Am J Surg. Feb 1984;147(2):243-5. [Medline].

  58. Strodel WE, Nostrant TT, Eckhauser FE, Dent TL. Therapeutic and diagnostic colonoscopy in nonobstructive colonic dilatation. Ann Surg. Apr 1983;197(4):416-21. [Medline].

  59. Jetmore AB, Timmcke AE, Gathright JB Jr, Hicks TC, Ray JE, Baker JW. Ogilvie's syndrome: colonoscopic decompression and analysis of predisposing factors. Dis Colon Rectum. Dec 1992;35(12):1135-42. [Medline].

  60. Bernton E, Myers R, Reyna T. Pseudoobstruction of the colon: case report including a new endoscopic treatment. Gastrointest Endosc. May 1982;28(2):90-2. [Medline].

  61. Fiorito JJ, Schoen RE, Brandt LJ. Pseudo-obstruction associated with colonic ischemia: successful management with colonoscopic decompression. Am J Gastroenterol. Oct 1991;86(10):1472-6. [Medline].

  62. Pham TN, Cosman BC, Chu P, Savides TJ. Radiographic changes after colonoscopic decompression for acute pseudo-obstruction. Dis Colon Rectum. Dec 1999;42(12):1586-91. [Medline].

  63. Gosche JR, Sharpe JN, Larson GM. Colonoscopic decompression for pseudo-obstruction of the colon. Am Surg. Feb 1989;55(2):111-5. [Medline].

  64. Messmer JM, Wolper JC, Loewe CJ. Endoscopic-assisted tube placement for decompression of acute colonic pseudo-obstruction. Endoscopy. Jul 1984;16(4):135-6. [Medline].

  65. Burke G, Shellito PC. Treatment of recurrent colonic pseudo-obstruction by endoscopic placement of a fenestrated overtube. Report of a case. Dis Colon Rectum. Aug 1987;30(8):615-9. [Medline].

  66. Harig JM, Fumo DE, Loo FD, Parker HJ, Soergel KH, Helm JF, et al. Treatment of acute nontoxic megacolon during colonoscopy: tube placement versus simple decompression. Gastrointest Endosc. Jan-Feb 1988;34(1):23-7. [Medline].

  67. Schermer CR, Hanosh JJ, Davis M, Pitcher DE. Ogilvie's syndrome in the surgical patient: a new therapeutic modality. J Gastrointest Surg. Mar-Apr 1999;3(2):173-7. [Medline].

  68. [Best Evidence] Sgouros SN, Vlachogiannakos J, Vassiliadis K, Bergele C, Stefanidis G, et al. Effect of polyethylene glycol electrolyte balanced solution on patients with acute colonic pseudo obstruction after resolution of colonic dilation: a prospective, randomised, placebo controlled trial. Gut. May 2006;55(5):638-42. [Medline].

  69. Carcoforo P, Jorizzo EF, Maestroni U, Soliani G, Bergossi L, Pozza E. A new approach to the cure of the Ogilvie's syndrome. Ann Ital Chir. Jan-Feb 2005;76(1):65-70. [Medline].

  70. Georgescu S, Dubei L, Zaharia M, Cîrdei C, Crumpei F, Cijevschi-Prelipcean C, et al. Ogilvie's syndrome--acute colonic pseudo-obstruction. Case report and review of the literature. Rom J Gastroenterol. Mar 2003;12(1):51-5. [Medline].

  71. Duh QY, Way LW. Diagnostic laparoscopy and laparoscopic cecostomy for colonic pseudo-obstruction. Dis Colon Rectum. Jan 1993;36(1):65-70. [Medline].

  72. Halverson A. Acute colonic pseudoobstruction. In: Cameron JL, ed. Current Surgical Therapy. 9th ed. Philadelphia: Mosby-Elsevier; 2008:192-195.

  73. Spira IA, Rodrigues R, Wolff WI. Pseudo-obstruction of the colon. Am J Gastroenterol. May 1976;65(5):397-408. [Medline].

Further Reading

Keywords

intestinal pseudoobstruction, colonic pseudo-obstruction, Ogilvie's syndrome, Ogilvie syndrome, large intestinal obstruction, large bowel obstruction, cecal perforation, abdominal distention, abdominal sepsis, anastomotic dehiscence, intestinal fistula, abdominal compartment syndrome

Contributor Information and Disclosures

Author

Burt Cagir, MD, FACS, Assistant Professor of Surgery, State University of New York, Upstate Medical Center; Consulting Staff, Director of Surgical Research, Robert Packer Hospital; Associate Program Director, Department of Surgery, Guthrie Clinic
Burt Cagir, MD, FACS is a member of the following medical societies: American College of Surgeons, American Medical Association, and Society for Surgery of the Alimentary Tract
Disclosure: Nothing to disclose.

Coauthor(s)

Lena M Napolitano, MD, FACS, FCCP, FCCM, Professor of Surgery, University of Michigan School of Medicine; Chief, Surgical Critical Care, Program Director, Surgical Critical Care Fellowship, Associate Chair, Department of Surgery, University of Michigan Health System
Lena M Napolitano, MD, FACS, FCCP, FCCM is a member of the following medical societies: Alpha Omega Alpha, American Association for the Surgery of Trauma, American College of Chest Physicians, American College of Critical Care Medicine, American College of Physicians, American College of Surgeons, American Medical Association, American Society for Parenteral and Enteral Nutrition, Association for Academic Surgery, Association of VA Surgeons, Association of Women Surgeons, California Professional Society on the Abuse of Children, Eastern Association for the Surgery of Trauma, Phi Beta Kappa, Shock Society, Society of Critical Care Medicine, and Society of University Surgeons
Disclosure: Nothing to disclose.

James Dunne, MD, Clinical Instructor, Department of Surgery, Trauma/Critical Care, University of Maryland Medical Center
James Dunne, MD is a member of the following medical societies: Society of Critical Care Medicine
Disclosure: Nothing to disclose.

Medical Editor

George Y Wu, MD, PhD, Professor, Department of Medicine, Director, Hepatology Section, Herman Lopata Chair in Hepatitis Research, University of Connecticut School of Medicine
George Y Wu, MD, PhD is a member of the following medical societies: American Association for the Study of Liver Diseases, American Gastroenterological Association, American Medical Association, American Society for Clinical Investigation, and Association of American Physicians
Disclosure: Humana Press Consulting fee Consulting; Novartis Consulting fee Review panel membership

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

James L Achord, MD, Professor Emeritus, Department of Medicine, Division of Digestive Diseases, University of Mississippi School of Medicine
James L Achord, MD is a member of the following medical societies: American Association for the Study of Liver Diseases, American College of Gastroenterology, American College of Physicians, American Gastroenterological Association, American Medical Association, American Society for Gastrointestinal Endoscopy, Mississippi State Medical Association, New York Academy of Sciences, Sigma Xi, and Southern Medical Association
Disclosure: Nothing to disclose.

CME Editor

Paolo Zamboni, MD, Professor of Surgery, Chief of Day Surgery Unit, Chair of Vascular Diseases Center, University of Ferrara, Italy
Paolo Zamboni, MD is a member of the following medical societies: American Venous Forum and New York Academy of Sciences
Disclosure: Nothing to disclose.

Chief Editor

John Geibel, MD, DSc, MA, Vice Chairman, Professor, Department of Surgery, Section of Gastrointestinal Medicine and Department of Cellular and Molecular Physiology, Yale University School of Medicine; Director of Surgical Research, Department of Surgery, Yale-New Haven Hospital
John Geibel, MD, DSc, MA is a member of the following medical societies: American Gastroenterological Association, American Physiological Society, American Society of Nephrology, Association for Academic Surgery, International Society of Nephrology, New York Academy of Sciences, and Society for Surgery of the Alimentary Tract
Disclosure: AMGEN Royalty Other

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.